Glaucoma
What the FAA's documents say about glaucoma, in plain words, with the FAA's own words one press away.
FAA term: Glaucoma (treated or untreated)
Short version
The FAA's table sorts it into two rows.
| Situation | What the examiner does | Pathway |
|---|---|---|
| Row AGlaucoma, treated or untreated, all classes. The table's evaluation data is to review all pertinent medical information and a current status report, including Form 8500-14. | Worksheet | CACI |
| Row BAll others. | Defers to the FAA | Special Issuance |
Show the FAA's words: the FAA's table for Glaucoma
- Row A · CACI
Glaucoma, treated or untreated, all classes. The table's evaluation data is to review all pertinent medical information and a current status report, including Form 8500-14. The table sends the examiner to the CACI worksheet for glaucoma. If the airman meets all certification criteria, the examiner issues.
Glaucoma (treated or untreated) … All … Review all pertinent medical information and current status report, including Form 8500-14 … See CACI – Glaucoma Worksheet ( PDF ) . If airman meets all certification criteria – Issue .
- Row B · Special Issuance
All others. The table's line reads required FAA decision, with all evaluation data submitted. An initial Special Issuance requires an FAA decision.
All others required FAA decision. Submit all evaluation data. … Initial Special Issuance – Requires FAA Decision
- A note on the table, 1
Above its rows, the Item 32 table says medical certificates must not be issued to an applicant with medical conditions that require deferral, or for any condition not listed that may result in sudden or subtle incapacitation, without consulting the AMCD or the RFS, and that medical documentation must be submitted for any condition in order to support an issuance of an airman medical certificate.
Medical certificates must not be issued to an applicant with medical conditions that require deferral, or for any condition not listed that may result in sudden or subtle incapacitation without consulting the AMCD or the RFS . Medical documentation must be submitted for any condition in order to support an issuance of an airman medical certificate.
The FAA pathways for glaucoma
Which exam
Your step-by-step plan
Step 1: The progress note from the treating doctor or specialist
The note the examiner reviews.Within 90 days before the examA current, detailed progress note from a clinic visit with your treating physician or specialist, no more than 90 days before the exam. Your AME reviews it.
Show the FAA's words: The progress note from the treating doctor or specialist
the AME must review a current, detailed Clinical Progress Note generated from a clinic visit with the treating physician or specialist no more than 90 days prior to the AME exam.
FAA source: CACI – Glaucoma Worksheet. FAA date 13 April 2022; checked by Crosscheck 14 October 2026.
Step 2: The eye report and the visual field test
FAA Form 8500-14 or an equivalent report, and your visual field testing.FAA Form 8500-14, or an equivalent report
FAA Form 8500-14, or an equivalent report from your treating physician, documenting the considerations the worksheet lists below it.
Visual field testing
No evidence of defect, and no reported unreliable visual fields.
Acceptable tests
- Humphrey 24-2 or 30-2 (either SITA or full threshold)
- Octopus (either TOP or full threshold)
Other formal visual field testing may be acceptable, but your AME must call for approval.
Not acceptable
- Not: Confrontation or screening visual field testing
Show the FAA's words: The eye report and the visual field test
FAA Form 8500-14 or equivalent treating physician report that documents the considerations below: [ ] Yes
FAA source: CACI – Glaucoma Worksheet. FAA date 13 April 2022; checked by Crosscheck 14 October 2026.
ANY evidence of defect or reported Unreliable Visual Fields Acceptable visual field tests: Humphrey 24-2 or 30-2 (either SITA or full threshold), Octopus (either TOP or full threshold). Other formal visual field testing may be acceptable but you must call for approval. Confrontation or screening visual field testing is not acceptable. [ ] No
FAA source: CACI – Glaucoma Worksheet. FAA date 13 April 2022; checked by Crosscheck 14 October 2026.
Step 3: The worksheet's criteria
Your eye medications, the type of glaucoma, eye pressure and the other criteria.None, or eye medications of the kinds the worksheet lists. Combination eye drops are acceptable.
The kinds the worksheet lists
- Prostaglandin analogs (Xalatan, Lumigan, Travatan or Travatan Z)
- Carbonic anhydrase inhibitor (Trusopt and Azopt)
- Beta blockers (Timoptic, etc)
- Alpha agonist (Alphagan)
Not acceptable for CACI
- Not: Pilocarpine or other miotics
- Not: Cycloplegics (atropine)
- Not: Oral medications
The worksheet's other criteria
- Stable on the current regimen, with no changes recommended by the treating ophthalmologist
- Age at diagnosis 40 or older
- An acceptable type: open angle, ocular hypertension or glaucoma suspect, monitored and stable; or a previous history of narrow angle or angle closure glaucoma treated with iridectomy or iridotomy (surgical or laser) and currently stable
- No documented nerve damage or trabeculectomy (filtration surgery)
- No medication side effects
- Intraocular pressure 23 mm Hg or less in both eyes
Types the worksheet does not accept
- Not: Normal tension glaucoma
- Not: Secondary glaucoma due to inflammation, trauma, or any other significant eye pathology
Show the FAA's words: The worksheet's criteria
Medications [ ] None or Prostaglandin analogs (Xalatan, Lumigan, Travatan or Travatan Z), Carbonic anhydrase inhibitor (Trusopt and Azopt), Beta blockers (Timoptic, etc), or Alpha agonist (Alphagan). Combination eye drops are acceptable
NOT acceptable for CACI: Pilocarpine or other miotics, cycloplegics (Atropine), or oral medications.
FAA source: CACI – Glaucoma Worksheet. FAA date 13 April 2022; checked by Crosscheck 14 October 2026.
CACI Glaucoma Medications
(as a single agent or in a combination product)
Beta-Blocker
betaxolol (Kerlone)
carteolol (Ocupress
levobunolol (Betagan)
timolol (Timoptic)
Carbonic Anhydrase Inhibitor
brinzolamide (Azopt)
dorzolamide (Trusopt)
methazolamide
Alpha2 Agonist
apraclonidine (Iopidine)
brimonidine (Alphagan P)
Rho Kinase Inhibitor
netarsudil (Rhopressa)
Prostaglandin
bimatoprost (Latisse; Lumigan)
latanoprost (Xalatan)
latanoprostene bunod (Vyzulta)
omidenepag isopropyl (Omlonti)
tafluprost (Zioptan)
travoprost (Travatan)
Combination
brimonidine + timolol (Combigan)
brinzolamide + brimonidine tartrate (Simbrinza)
netarsudil + latanoprost (Rocklatan)
dorzolamide + timolol (Cosopt)
FAA source: Glaucoma and Ocular Hypertension Medications. FAA date 27 August 2025; checked by Crosscheck 14 October 2026.
CONDITIONALLY ACCEPTABLE Glaucoma Medications (Requires SI)
(as a single agent or in a combination product)
Oral medications
e.g. acetazolamide (Diamox)
UNACCEPTABLE Glaucoma Medications
Cycloplegics
e.g. atropine
Cholinergic Agonist
e.g. pilocarpine (Salagen, Isopto Carpine)
FAA source: Glaucoma and Ocular Hypertension Medications. FAA date 27 August 2025; checked by Crosscheck 14 October 2026.
Treating ophthalmologist finds the condition stable on current regimen and no changes recommended. [ ] Yes
FAA source: CACI – Glaucoma Worksheet. FAA date 13 April 2022; checked by Crosscheck 14 October 2026.
Age at diagnosis [ ] 40 or older
FAA source: CACI – Glaucoma Worksheet. FAA date 13 April 2022; checked by Crosscheck 14 October 2026.
Acceptable types of glaucoma [ ] Open Angle being monitored and stable, Ocular Hypertension or Glaucoma Suspect being monitored and stable, or previous history of Narrow Angle/Angle Closure Glaucoma which has been treated with iridectomy/iridotomy (surgical or laser) and is currently stable.
NOT acceptable: Normal Tension Glaucoma, secondary glaucoma due to inflammation, trauma, or the presence of any other significant eye pathology (e.g. neovascular glaucoma due to proliferative diabetic retinopathy or an ischemic central vein occlusion or uveitic glaucoma)
FAA source: CACI – Glaucoma Worksheet. FAA date 13 April 2022; checked by Crosscheck 14 October 2026.
Documented nerve damage or trabeculectomy (filtration surgery) [ ] No
FAA source: CACI – Glaucoma Worksheet. FAA date 13 April 2022; checked by Crosscheck 14 October 2026.
Medication side effects [ ] None
FAA source: CACI – Glaucoma Worksheet. FAA date 13 April 2022; checked by Crosscheck 14 October 2026.
Intraocular pressure [ ] 23 mm Hg or less in both eyes
FAA source: CACI – Glaucoma Worksheet. FAA date 13 April 2022; checked by Crosscheck 14 October 2026.
What the examiner checks
It depends on which row of the FAA's table describes the case.
Row AWorksheetCACI
The table sends the examiner to the CACI worksheet for glaucoma. If the airman meets all certification criteria, the examiner issues.
Row BDefers to the FAASpecial Issuance
The table's line reads required FAA decision, with all evaluation data submitted. An initial Special Issuance requires an FAA decision.
If the examiner defers
Show the FAA's words: what the examiner does on each row
- Row A · CACI
Glaucoma, treated or untreated, all classes. The table's evaluation data is to review all pertinent medical information and a current status report, including Form 8500-14. The table sends the examiner to the CACI worksheet for glaucoma. If the airman meets all certification criteria, the examiner issues.
Glaucoma (treated or untreated) … All … Review all pertinent medical information and current status report, including Form 8500-14 … See CACI – Glaucoma Worksheet ( PDF ) . If airman meets all certification criteria – Issue .
- Row B · Special Issuance
All others. The table's line reads required FAA decision, with all evaluation data submitted. An initial Special Issuance requires an FAA decision.
All others required FAA decision. Submit all evaluation data. … Initial Special Issuance – Requires FAA Decision
The CACI worksheet's criteria
Visual field testing
Acceptable tests
- Humphrey 24-2 or 30-2 (either SITA or full threshold)
- Octopus (either TOP or full threshold)
Other formal visual field testing may be acceptable, but your AME must call for approval.
Not acceptable
- Not: Confrontation or screening visual field testing
Your glaucoma medications
The kinds the worksheet lists
- Prostaglandin analogs (Xalatan, Lumigan, Travatan or Travatan Z)
- Carbonic anhydrase inhibitor (Trusopt and Azopt)
- Beta blockers (Timoptic, etc)
- Alpha agonist (Alphagan)
Not acceptable for CACI
- Not: Pilocarpine or other miotics
- Not: Cycloplegics (atropine)
- Not: Oral medications
The worksheet's other criteria
- Stable on the current regimen, with no changes recommended by the treating ophthalmologist
- Age at diagnosis 40 or older
- An acceptable type: open angle, ocular hypertension or glaucoma suspect, monitored and stable; or a previous history of narrow angle or angle closure glaucoma treated with iridectomy or iridotomy (surgical or laser) and currently stable
- No documented nerve damage or trabeculectomy (filtration surgery)
- No medication side effects
- Intraocular pressure 23 mm Hg or less in both eyes
Types the worksheet does not accept
- Not: Normal tension glaucoma
- Not: Secondary glaucoma due to inflammation, trauma, or any other significant eye pathology
Show the FAA's words: the CACI worksheet's criteria for Glaucoma
- Stable on the current regimen, with no changes recommended
FAA criterion: the treating ophthalmologist finds the condition stable on the current regimen, with no changes recommended.
Treating ophthalmologist finds the condition stable on current regimen and no changes recommended. [ ] Yes
- Age at diagnosis 40 or older
FAA criterion: age at diagnosis 40 or older.
Age at diagnosis [ ] 40 or older
- An acceptable type of glaucoma
FAA criterion: the acceptable types of glaucoma are open angle being monitored and stable, ocular hypertension or glaucoma suspect being monitored and stable, or a previous history of narrow angle or angle closure glaucoma which has been treated with iridectomy or iridotomy (surgical or laser) and is currently stable. The worksheet names as not acceptable normal tension glaucoma, and secondary glaucoma due to inflammation, trauma, or the presence of any other significant eye pathology, with its own examples in its own terms.
Acceptable types of glaucoma [ ] Open Angle being monitored and stable, Ocular Hypertension or Glaucoma Suspect being monitored and stable, or previous history of Narrow Angle/Angle Closure Glaucoma which has been treated with iridectomy/iridotomy (surgical or laser) and is currently stable. … NOT acceptable: Normal Tension Glaucoma, secondary glaucoma due to inflammation, trauma, or the presence of any other significant eye pathology (e.g. neovascular glaucoma due to proliferative diabetic retinopathy or an ischemic central vein occlusion or uveitic glaucoma)
- No documented nerve damage or trabeculectomy (filtration surgery)
FAA criterion: no documented nerve damage or trabeculectomy (filtration surgery).
Documented nerve damage or trabeculectomy (filtration surgery) [ ] No
- No medication, or medications from the kinds the worksheet lists
FAA criterion: none, or prostaglandin analogs (Xalatan, Lumigan, Travatan or Travatan Z), a carbonic anhydrase inhibitor (Trusopt and Azopt), beta blockers (Timoptic, etc), or an alpha agonist (Alphagan); the worksheet says combination eye drops are acceptable. It names as not acceptable for CACI pilocarpine or other miotics, cycloplegics (atropine), or oral medications. The FAA's Glaucoma and Ocular Hypertension Medications sheet has its own list of CACI glaucoma medications, as a single agent or in a combination product, under beta-blocker, carbonic anhydrase inhibitor (including methazolamide), alpha2 agonist, rho kinase inhibitor, prostaglandin and combination; it lists oral medications, such as acetazolamide (Diamox), as conditionally acceptable, requiring an SI, and cycloplegics, such as atropine, and cholinergic agonists, such as pilocarpine, as unacceptable. Crosscheck reports both lists as published and does not decide between them.
Medications [ ] None or Prostaglandin analogs (Xalatan, Lumigan, Travatan or Travatan Z), Carbonic anhydrase inhibitor (Trusopt and Azopt), Beta blockers (Timoptic, etc), or Alpha agonist (Alphagan). Combination eye drops are acceptable … NOT acceptable for CACI: Pilocarpine or other miotics, cycloplegics (Atropine), or oral medications.
CACI Glaucoma Medications … (as a single agent or in a combination product) … Beta-Blocker … betaxolol (Kerlone) … carteolol (Ocupress … levobunolol (Betagan) … timolol (Timoptic) … Carbonic Anhydrase Inhibitor … brinzolamide (Azopt) … dorzolamide (Trusopt) … methazolamide … Alpha2 Agonist … apraclonidine (Iopidine) … brimonidine (Alphagan P) … Rho Kinase Inhibitor … netarsudil (Rhopressa) … Prostaglandin … bimatoprost (Latisse; Lumigan) … latanoprost (Xalatan) … latanoprostene bunod (Vyzulta) … omidenepag isopropyl (Omlonti) … tafluprost (Zioptan) … travoprost (Travatan) … Combination … brimonidine + timolol (Combigan) … brinzolamide + brimonidine tartrate (Simbrinza) … netarsudil + latanoprost (Rocklatan) … dorzolamide + timolol (Cosopt)
CONDITIONALLY ACCEPTABLE Glaucoma Medications (Requires SI) … (as a single agent or in a combination product) … Oral medications … e.g. acetazolamide (Diamox) … UNACCEPTABLE Glaucoma Medications … Cycloplegics … e.g. atropine … Cholinergic Agonist … e.g. pilocarpine (Salagen, Isopto Carpine)
- No medication side effects
FAA criterion: no medication side effects.
Medication side effects [ ] None
- Intraocular pressure 23 mm Hg or less in both eyes
FAA criterion: intraocular pressure 23 mm Hg or less in both eyes.
Intraocular pressure [ ] 23 mm Hg or less in both eyes
- Visual field testing, with no evidence of defect and no reported unreliable visual fields
FAA criterion: no evidence of defect and no reported unreliable visual fields. The worksheet's acceptable visual field tests are Humphrey 24-2 or 30-2 (either SITA or full threshold) and Octopus (either TOP or full threshold). It says other formal visual field testing may be acceptable, but the examiner must call for approval, and that confrontation or screening visual field testing is not acceptable.
ANY evidence of defect or reported Unreliable Visual Fields Acceptable visual field tests: Humphrey 24-2 or 30-2 (either SITA or full threshold), Octopus (either TOP or full threshold). Other formal visual field testing may be acceptable but you must call for approval. Confrontation or screening visual field testing is not acceptable. [ ] No
If the examiner defersSpecial Issuance
The table's line for all others reads required FAA decision, with all evaluation data submitted, and it says an initial Special Issuance requires an FAA decision.
When the pilot is not CACI qualified, the worksheet has the examiner note in Block 60 that they have deferred, and submit supporting documents.
What the FAA lists to send
- Item 1. All evaluation data. The table's evaluation data for glaucoma is all pertinent medical information and a current status report, including Form 8500-14.
Show the FAA's words: if the examiner defers
When the examiner defers
- Reason 1
The table's line for all others reads required FAA decision, with all evaluation data submitted, and it says an initial Special Issuance requires an FAA decision.
All others required FAA decision. Submit all evaluation data. … Initial Special Issuance – Requires FAA Decision
- Reason 2
When the pilot is not CACI qualified, the worksheet has the examiner note in Block 60 that they have deferred, and submit supporting documents.
AME MUST NOTE in Block 60 one of the following: … NOT CACI qualified glaucoma. I have deferred. (Submit supporting documents.)
What the FAA lists to send
- Item 1
All evaluation data. The table's evaluation data for glaucoma is all pertinent medical information and a current status report, including Form 8500-14.
Review all pertinent medical information and current status report, including Form 8500-14 … All others required FAA decision. Submit all evaluation data.
After the FAA decides
AASIThe table says an initial Special Issuance requires an FAA decision, and for followup Special Issuances it points to the AASI protocol. The FAA's AASI sheet for glaucoma says an FAA physician provides the initial certification decision and grants the Authorization, and that for a first-time AASI application, with all the medical information needed for a determination, the examiner must defer and submit all of it to the AMCD or RFS for the initial determination.
Show the FAA's words: after the FAA decides
Initial Special Issuance – Requires FAA Decision … Followup Special Issuances – See AASI Protocol
An FAA physician provides the initial certification decision and grants the Authorization in accordance with 14 CFR § 67.401 . … If this is a first-time application for an AASI for the above disease/condition, and the applicant has all the requisite medical information necessary for a determination, the Examiner must defer and submit all of the documentation to the AMCD or RFS for the initial determination.
What a Special Issuance is
The Guide says an Authorization for Special Issuance, valid for a specified period, may be granted at the Federal Air Surgeon's discretion to a person who does not meet the established medical standards, if the person shows to the satisfaction of the Federal Air Surgeon that the duties authorized by the class of certificate applied for can be performed without endangering public safety during the period the Authorization would be in force.
How the FAA pathways workAt later examsAASI
- First and second class
- Every year
- Third class
- At each required exam
The worksheet says first- and second-class applicants must provide this information every year, and third-class applicants must provide it with each required exam.
Show the FAA's words: how often the FAA asks again
Applicants for first- or second- class must provide this information annually; applicants for third-class must provide the information with each required exam.
Under an FAA Authorization, the FAA's AASI sheet for glaucoma lists what the pilot provides for the examiner to reissue. That is the Authorization granted by the FAA; certification only granted for open-angle glaucoma and ocular hypertension; FAA Form 8500-14, the Glaucoma Eye Evaluation Form, filled out by the treating eye specialist; and a set of visual field measurements. The sheet says the Authorization letter comes with attachments that specify the information the treating doctors must provide for the reissue determination.
Show the FAA's words: at later exams
The Authorization letter is accompanied by attachments that specify the information that treating physician(s) must provide for the re-issuance determination. … Examiners may re-issue an airman medical certificate under the provisions of an Authorization, if the applicant provides the following: … An Authorization granted by the FAA; … Certification only granted for open-angle-glaucoma and ocular hypertension; … The FAA Form 8500-14, Glaucoma Eye Evaluation Form is filled out by the treating eye specialist; and … A set of visual fields measurements is provided.
What AASI is
AASI stands for AME Assisted Special Issuance. The Guide describes it as a process that lets the examiner reissue a certificate under the provisions of an Authorization for Special Issuance, to an applicant who has a medical condition that is disqualifying under 14 CFR part 67.
How the FAA pathways workThe Authorization granted by the FAA
The AASI sheet's list for a reissue begins with an Authorization granted by the FAA.
Show the FAA's words: The Authorization granted by the FAA
Examiners may re-issue an airman medical certificate under the provisions of an Authorization, if the applicant provides the following: … An Authorization granted by the FAA;
Certification only granted for open-angle glaucoma and ocular hypertension
The AASI sheet's list says certification is only granted for open-angle glaucoma and ocular hypertension.
Show the FAA's words: Certification only granted for open-angle glaucoma and ocular hypertension
Certification only granted for open-angle-glaucoma and ocular hypertension;
FAA Form 8500-14, filled out by the treating eye specialist
The AASI sheet asks for FAA Form 8500-14, the Glaucoma Eye Evaluation Form, filled out by the treating eye specialist.
Show the FAA's words: FAA Form 8500-14, filled out by the treating eye specialist
The FAA Form 8500-14, Glaucoma Eye Evaluation Form is filled out by the treating eye specialist; and
A set of visual field measurements
The AASI sheet asks for a set of visual field measurements.
Show the FAA's words: A set of visual field measurements
A set of visual fields measurements is provided.
What the Authorization letter comes with
The AASI sheet says the Authorization letter comes with attachments that specify the information the treating physicians must provide for the reissue determination.
Show the FAA's words: What the Authorization letter comes with
The Authorization letter is accompanied by attachments that specify the information that treating physician(s) must provide for the re-issuance determination.
When the examiner defers a reissue
The AASI sheet says the examiner must defer to the AMCD or Region if FAA Form 8500-14 shows visual acuity incompatible with the medical standards, or if there is a change in visual fields or an adverse change in ocular pressure.
Show the FAA's words: When the examiner defers a reissue
The Examiner must defer to the AMCD or Region if: … The FAA Form 8500-14 Glaucoma Eye Evaluation Form demonstrates visual acuity incompatible with the medical standards; or … There is a change in visual fields or adverse change in ocular pressure.
Good to know
Points from the FAA's own documents that are easy to miss.
What a progress note must include
In most cases it should come from a visit with the treating physician no more than 90 days ago, and cover the history, medications with dosages and side effects, exam findings, test results, diagnosis, assessment and plan, prognosis and follow-up. The FAA's sheet says to make sure the physician adds the prognosis. A portal note or an After Visit Summary that does not meet these criteria is not enough, and neither is a simple "ok to fly" letter. The FAA's documents also call it a status report.
Show the FAA's words: good to know, 1
your patient portal to print out “notes” or an “After Visit Summary (AVS).” … Patient Portal notes or an AVS that do not meet the criteria listed below for a detailed Clinical Progress Note are NOT sufficient for FAA purposes. … To be “current,” in MOST CASES, the detailed Clinical Progress Note should be from an evaluation in which you saw your treating physician no more than 90 days ago. … It Must include the following items: … A summary of the history of the condition, … Current medications, dosages, and side effects (if any); … Clinical exam findings; … Results of any testing performed; … Diagnosis; … Assessment and Plan; … Prognosis (This item may not be on a standard progress note, make sure your physician adds this information.); and … Follow-up … Please note: A letter stating, “Mr. Smith is ok to fly” (or any other simple note), is NOT a current, detailed Clinical Progress Note and is NOT acceptable. … You may also see this called a “current status report” or “status report” in current FAA Guidance. Any reference to a “status report” equals the criteria listed on this sheet.
Two FAA medication lists differ
The worksheet and the FAA's Glaucoma and Ocular Hypertension Medications sheet are two lists. The sheet's CACI list names medications the worksheet's line does not, such as netarsudil and methazolamide. Crosscheck shows both and does not decide.
Show the FAA's words: good to know, 2
Medications [ ] None or Prostaglandin analogs (Xalatan, Lumigan, Travatan or Travatan Z), Carbonic anhydrase inhibitor (Trusopt and Azopt), Beta blockers (Timoptic, etc), or Alpha agonist (Alphagan). Combination eye drops are acceptable
CACI Glaucoma Medications … Carbonic Anhydrase Inhibitor … brinzolamide (Azopt) … dorzolamide (Trusopt) … methazolamide … Rho Kinase Inhibitor … netarsudil (Rhopressa)
Block 60 carries one of three statements
The worksheet says the examiner must note one of three in Block 60: CACI qualified (documents do not need to be submitted to the FAA); has current or previous SI/AASI but now CACI qualified; or NOT CACI qualified, which says the examiner has deferred and to submit supporting documents.
Show the FAA's words: good to know, 3
AME MUST NOTE in Block 60 one of the following: … CACI qualified glaucoma. (Documents do not need to be submitted to the FAA.) … Has current OR previous SI/AASI but now CACI qualified glaucoma. … NOT CACI qualified glaucoma. I have deferred. (Submit supporting documents.)
FAA sources
Every FAA document this page relies on, with the FAA's own date and the date Crosscheck last read it. The documents to print open at the FAA, so they are always the FAA's current ones.
- Open to print: CACI – Glaucoma Worksheet, a PDF at the FAA, in a new tab
- Glaucoma (Item 32)Open to print: Glaucoma (Item 32), a page at the FAA, in a new tab
Special Issuance
- Open to print: AASI – Glaucoma, a page at the FAA, in a new tab
- Open at the FAA: Glaucoma and Ocular Hypertension Medications, a PDF at the FAA, in a new tab
- Open at the FAA: Pilot Information – What a Detailed Clinical Progress Note must contain, a PDF at the FAA, in a new tab
This reports what the FAA has published. It is not medical advice, and it does not say how the FAA or an examiner will decide a case.